Equity Method Investment - Schedule of Equity Method Investments (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Equity Method Investments [Line Items] | ||||
| Change in claim on net assets of Gannet BioChem | $ (319) | $ (2,386) | $ (2,069) | $ (6,847) |
| Gannet BioChem | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Claim on net assets of Gannet BioChem - beginning of period | 1,741 | 7,757 | 3,491 | 12,218 |
| Claim on net assets of Gannet BioChem - end of period | 1,422 | 5,371 | 1,422 | 5,371 |
| Change in claim on net assets of Gannet BioChem | $ (319) | $ (2,386) | $ (2,069) | $ (6,847) |
| X | ||||||||||
- Definition This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|